Used in research settings to measure levels of procollagen type III C-terminal peptide in biological samples, aiding in the assessment of collagen synthesis and turnover. Commonly applied in studies related to liver fibrosis, particularly in evaluating the progression or regression of hepatic fibrosis in chronic liver diseases such as hepatitis and fatty liver disease. Also utilized in dermatological research to monitor skin repair and fibrosis, and in cardiovascular studies where tissue remodeling is a factor. The kit enables quantitative analysis, supporting both clinical research and drug development efforts focused on fibrotic disorders.